IP Library Granted Patent US 10,150,955
Granted Patent B2
US 10,150,955 · App. 15/164,208 · Granted Dec 11, 2018

Stabilized reverse transcriptase fusion proteins

Inventors: Alan M. Lambowitz (Austin, TX); Sabine Mohr (Austin, TX); Georg Mohr (Austin, TX); Eman Ghanem (Austin, TX)
Assignee: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
C12N9/1276C12P19/34C12Y207/07049C07K2319/00C07K2319/24
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,150,955
App. No.
15/164,208
Granted
Dec 11, 2018
Kind
B2
Abstract

Stabilized reverse transcriptase fusion proteins including a thermostable reverse transcriptase connected to a stabilizer protein are described. Attaching the stabilizer protein to the thermostable reverse transcriptase stabilizes the fusion protein and can aid in its purification, provide increased solubility, allow for longer storage, or allow the fusion protein to be used under more rigorous conditions such as higher temperature. The stabilized reverse transcriptase fusion protein can also include a linker between the stabilizer protein and the thermostable reverse temperature. The stabilized reverse transcriptase fusion proteins are suitable for use in nucleic acid amplification methods such as the reverse transcription polymerase chain reaction and other applications involving cDNA synthesis.

Claims (12)

1. A method of reverse transcription, comprising carrying out reverse transcription of an RNA template using a stabilized reverse transcriptase fusion protein comprising a group-II intron-derived reverse transcriptase connected at its N-terminus by a linker peptide to the C-terminus of a stabilizer protein comprising 50 or more amino acids, wherein the fusion protein exhibits increased solubility and stability in solution.

2. The method of claim 1 , wherein the reverse transcriptase comprises a polypeptide having at least 85% amino acid sequence identity to a sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, or SEQ ID NO: 5.

3. The method of claim 1 , wherein the stabilized reverse transcriptase fusion protein comprises an amino acid sequence with at least 85% amino acid sequence identity to a sequence selected from the group consisting of SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, SEQ ID NO: 9, or SEQ ID NO: 10.

4. The method of claim 1 , wherein the solubility-enhancing stabilizer protein comprises a maltose binding protein or an N-utilization substance A protein.

5. The method of claim 1 , wherein the solubility-enhancing stabilizer protein does not fold into long-lived misfolded intermediates.

6. The method of claim 1 , wherein the linker peptide is a non-cleavable linker peptide.

7. The method of claim 1 , wherein the linker peptide is a rigid linker peptide.

8. The method of claim 1 , wherein the reverse transcription is carried out with an error frequency of 2.0×10 −5 or less at a temperature from about 45° to about 65° C.

9. The method of claim 1 , wherein the solubility-enhancing stabilizer protein includes an independent folding domain.

10. The method of claim 7 , wherein the rigid linker peptide consists of 3 to 5 amino acids.

11. The method of claim 10 , wherein the rigid linker peptide consists of SEQ ID NO: 12 or SEQ ID NO: 18.

12. A method of reverse transcription, comprising carrying out reverse transcription of an RNA template using a stabilized reverse transcriptase fusion protein comprising a group-II intron-derived reverse transcriptase connected at its N-terminus to the C-terminus of a stabilizer protein comprising 50 or more amino acids, wherein the fusion protein exhibits increased solubility and stability in solution.

Assignments (1)
CONFIRMATORY LICENSE Recorded Jul 21, 2016
From: UNIVERSITY OF TEXAS, AUSTIN
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 039421/0033 →
Continuity (3)
Division 13254223
Provisional Application 61157332 · Mar 4, 2009
Related Publication 20160289652A1 · Oct 6, 2016
Cited By (24)
US 12,281,303 US 12,281,338 US 12,319,938 US 12,344,869 US 12,351,814 US 12,351,815 US 12,351,837 US 12,359,218 US 12,390,514 US 12,404,525 US 12,406,749 US 12,435,330 US 12,435,331 US 12,473,543 US 12,473,573 US 12,509,680 US 12,516,308 US 12,522,807 US 12,559,737 US 12,570,972 US 12,584,118 US 12,624,353 US 12,624,354 US 12,668,815